Beth Mole, Ars Technica

Beth Mole

Ars Technica

Washington, DC, United States

Contact Beth

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • Ars Technica
  • Ars Technica UK
  • Science News

Past articles by Beth:

Florida surgeon general wrong on vaccines and bad at his job, CDC and FDA say

Ladapo has repeatedly peddled falsehoods about COVID-19 vaccines. → Read More

Gun violence is the top killer of US kids—the pandemic made it worse

Researchers call for firearm policy changes and efforts to address structural racism. → Read More

COVID survivors at increased risk of long-term gastrointestinal conditions

Although people with severe COVID had highest risk, mild cases also upped risks. → Read More

Moderna CEO says private investors funded COVID vaccine—not billions from gov’t

Bancel claimed billions in federal funding merely accelerated development. → Read More

Hospital’s water purification system stripped out chlorine, killing 3 patients

It was supposed to improve taste, but instead led to deadly infections. → Read More

Measles exposure at massive religious event in Kentucky spurs CDC alert

Kentucky has one of the lowest vaccination rates among kindergartners in the country. → Read More

WHO “deeply frustrated” by lack of US transparency on COVID origin data

Politicization makes the world less safe, WHO said, as it called on US to share data. → Read More

US woman headed to jail for refusing TB treatment for over a year

Washington judge issued an arrest warrant and ordered her to involuntary detention. → Read More

Musk’s bid to start Neuralink human trials denied by FDA in 2022, report says

FDA reportedly listed dozens of "deficiencies," including serious safety concerns. → Read More

Eli Lilly cuts insulin prices after years of outrage

Advocates say it's a long overdue start to fixing outrageously high prices. → Read More

FDA official behind Alzheimer’s drug scandal steps down

Investigations alleged Billy Dunn had inappropriately close relationship with drug maker. → Read More

Energy Dept. leans toward lab leak as COVID origin, at odds with other agencies

"There is not a definitive answer that has emerged from the intelligence community." → Read More

As COVID vaccine patent dispute drags on, Moderna forks over $400M to NIH

Moderna called the sum a "catch-up payment" for borrowing a molecular technique. → Read More

81% of international flights into NYC had SARS-CoV-2 in waste, small trial finds

The study demonstrated feasibility as COVID surveillance nose-dives worldwide. → Read More

Florida surgeon general fudged data for dubious COVID analysis, tipster says

The state closed the investigation, leaving more questions than answers. → Read More

Sour fight ends with FDA ruling soy and nut milks can still be called “milk”

FDA found that Americans are generally not confused about what's actually milk. → Read More

Unvaccinated more likely to have heart attack, stroke after COVID, study finds

Being fully vaccinated reduced the risk by about 41 percent. → Read More

Bonkers Republican bill in Idaho would make mRNA-based vaccination a crime

It's unclear if the two lawmakers know what messenger RNA is exactly. → Read More

Risk of diabetes rises 58% after COVID, even amid omicron, study finds

This is the latest study finding COVID infections can spur the development of diabetes. → Read More

Outbreak of Marburg, Ebola’s similarly deadly relative, spurs response race

Nine people have already died, making it the deadliest outbreak in over a decade. → Read More